Renal Retransplantation: A Retrospective Monocentric Study

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1345-1348

  Ott, U ^a   Busch, M ^a   Steiner, T ^a   Schubert, J ^a   Wolf, G ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CORTICOSTEROID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; BK VIRUS NEPHROPATHY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; NEOPLASM; PRIORITY JOURNAL; RENAL GRAFT DYSFUNCTION; RETRANSPLANTATION; RETROSPECTIVE STUDY; RISK REDUCTION; SEPSIS; SKIN CANCER;

ADULT; AGED; COHORT STUDIES; FEMALE; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; TISSUE DONORS; TREATMENT FAILURE;

EID: 45449088335     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.01.068     Document Type: Article

References (20)

1. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. Nephrol Dial Transplant 17 (2002) 1
2. Magee J.C., Barr M.L., Basadonna G.P., et al. Repeat organ transplantation in the United States, 1996-2005. Am J Transplant 7 (2007) 1424
3. Thompson J.S., Thacker L.R., and Krishnan G. Human leukocyte antigens DR and AB and kidney retransplantation. Transplantation 75 (2003) 718
4. Lenaers J., Christiaans M., van Heurn E., et al. Frequent but late donor-directed antibody formation after kidney transplantectomy within one month after grafting. Transplantation 81 (2006) 614
5. Doxiadis I.I., and Claas F.H. Donor-specific antibodies arising after kidney transplantectomy: priming or memory?. Transplantation 81 (2006) 509
6. Kamoun M., Whitney-Miller C., Kearns J., et al. A successful kidney transplant in a patient re-grafted across an incompatible crossmatch secondary to anti-HLA-DP antibodies using intensive immunosuppression. Am J Transplant 82 (2006) 1456
7. Barocci S., Valente U., and Nocera A. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation. Clin Transpl 21 (2007) 47
8. Vasilescu E.R., Ho E.K., Colovai A.I., et al. Alloantibodies and the outcome of cadaver kidney allografts. Hum Immunol 67 (2006) 597
9. Brukàmp K., Constantinescu S., Bloom R., et al. Transplant nephrectomy: impact on patient sensitization and histologic features. Am J Transplant 82 (2006) 1512
10. Almond P.S., Matas A.J., Gillingham K., et al. Risk factors for second renal allografts immunosuppressed with cyclosporine. Transplantation 52 (1991) 253
11. Weimer R., Süsal C., Yildiz S., et al. Post-transplant sCD30 and neopterin as predictors of chronic allograft nephropathy: impact of different immunosuppressive regimens. Am J Transplant 6 (2006) 1865
12. Rajab A., Pelletier R.P., Henry M.L., et al. Excellent clinical outcomes in second kidney transplant recipient treated with Rapamune based immunosuppression. Am J Transplant 82 (2006) 1499
13. Thibaudin D., Alamartine E., de Filippis J.P., et al. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. Nephrol Dial Transplant 13 (1998) 711
14. Mariat C., Afiani A., Alamartine E., et al. A pilot study comparing basiliximab and anti-thymocyte globulin as induction therapy in sensitized renal allograft recipients. Transplant Proc 33 (2001) 3192
15. Brennan D.C., Daller J.A., Lake K.D., et al., Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med 355 (2006) 1967
16. Josephson M.A. Rabbit antithymocyte globulin or basiliximab for induction therapy?. N Engl J Med 355 (2006) 2033
17. Miles C.D., Schaubel D.E., Jia X., et al. Mortality experience in recipients undergoing repeat transplantation with expanded criteria donor and non-ECD deceased-donor kidneys. Am J Transplant 7 (2007) 1140
18. Gjertson D.W. A multi-factor analysis of kidney regraft outcomes. Clin Transpl (2002) 335
19. Ojo A., Wolfe R.A., Agodoa L.Y., et al. Prognosis after primary renal transplant failure and the beneficial effects of repeat transplantation: multivariate analyses from the United States Renal Data System. Transplantation 66 (1998) 1651
20. Rao P.S., Schaubel D.E., and Saran R. Impact of graft failure on patient survival on dialysis: a comparison of transplant-naive and post-graft failure mortality rates. Nephrol Dial Transplant 20 (2005) 387